Literature DB >> 24372657

Incidence and risk factors for winged scapula after surgical treatment for breast cancer.

Adriana de S Mastrella1, Ruffo Freitas-Junior, Régis R Paulinelli, Leonardo R Soares.   

Abstract

AIMS AND
OBJECTIVES: To evaluate the incidence of winged scapula following surgical breast cancer treatment, determine its evolution over time and correlate factors that might influence this incidence.
BACKGROUND: Winged scapula is a complication that may occur as a result of exposing the long thoracic nerve during axillary lymphadenectomy for the treatment for breast cancer. There is no consensus in the literature about the incidence of this complication after surgical treatment for breast cancer, and complication rates range from 1·5-74%.
DESIGN: This is a prospective cohort study.
METHODS: A prospective cohort study was conducted including 57 patients with breast cancer who underwent surgical treatment. Each patient was assessed before and after the surgery, by means of Hoppenfeld manoeuvre. The incidence rate of winged scapula was calculated at four different times.
RESULTS: At the preoperative assessment, none of the patients presented with winged scapula, while 16 patients (28·1%) were shown to have this complication after the procedure. The incidence of winged scapula decreased over time. Factors associated with winged scapula were as follows: patients younger than 50 years, clinical stage I and II and no neoadjuvant chemotherapy. Other factors that were evaluated, such as type of surgery, number of lymph nodes compromised and removed, as well as body mass index, were not associated with the risk of winged scapula.
CONCLUSIONS: This study demonstrated that the incidence of winged scapula is low and decreased over time. Furthermore, a greater incidence of winged scapula was noted in young women at an initial stage of the disease who had not been treated with neoadjuvant chemotherapy. RELEVANCE TO CLINICAL PRACTICE: The result of this work may have great impact, for demonstrating what risk factors are significantly associated with winged scapula after surgical treatment for breast cancer.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  axillary lymphadenectomy; breast; breast cancer; long thoracic nerve; winged scapula

Mesh:

Year:  2013        PMID: 24372657     DOI: 10.1111/jocn.12443

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Long thoracic nerve injury in breast cancer patients treated with axillary lymph node dissection.

Authors:  Roser Belmonte; Sandra Monleon; Neus Bofill; Martha Ligia Alvarado; Josep Espadaler; Inmaculada Royo
Journal:  Support Care Cancer       Date:  2014-07-18       Impact factor: 3.603

2.  Winged scapula incidence and upper limb morbidity after surgery for breast cancer with axillary dissection.

Authors:  Samantha Karlla Lopes de Almeida Rizzi; Cinira Assad Simão Haddad; Patricia Santolia Giron; Thaís Lúcia Pinheiro; Afonso Celso Pinto Nazário; Gil Facina
Journal:  Support Care Cancer       Date:  2016-01-22       Impact factor: 3.603

3.  Winged scapula following axillary thoracotomy with long thoracic nerve preservation.

Authors:  Tomomi Isono; Shigeshi Mori; Hidenori Kusumoto; Hiroyuki Shiono
Journal:  BMJ Case Rep       Date:  2020-02-19

4.  Complete axillary dissection without drainage for the surgical treatment of breast cancer: a randomized clinical trial.

Authors:  Ruffo Freitas-Junior; Luís Fernando Jubé Ribeiro; Marise Amaral Rebouças Moreira; Geraldo Silva Queiroz; Maurício Duarte Esperidião; Marco Aurélio Costa Silva; Rubens José Pereira; Rossana Araújo Catão Zampronha; Rosemar Macedo Sousa Rahal; Leonardo Ribeiro Soares; Danielle Laperche Dos Santos; Maria Virginia Thomazini; Cassiana Ferreira Silva de Faria; Régis Resende Paulinelli
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

5.  Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa.

Authors:  Iwona Głowacka-Mrotek; Magdalena Tarkowska; Tomasz Nowikiewicz; Zygmunt Siedlecki; Wojciech Zegarski; Wojciech Hagner
Journal:  Contemp Oncol (Pozn)       Date:  2018-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.